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Menadione
MitochondriaMenadione (MEN), a polycyclic aromatic ketone, was shown to promote cell injury by imposing massive oxida-
tive stress and has been proposed as a promising chemotherapeutic agent for the treatment of cancer diseases.
The mechanisms underlying MEN-induced mitochondrial dysfunction and cell death are not yet fully under-
stood. In this work, a systematic study was performed to unveil the effects of MEN onmembrane lipid organiza-
tion, usingmodelsmimickingmitochondrial membranes and nativemitochondrial membranes. MENwas found
to readily incorporate in membrane systems composed of a single phospholipid (phosphatidylcholine) or
the lipids dioleoylphosphatidylcholine, dioleoylphosphatidylethanolamine and tetraoleoylcardiolipin at 1:1:1
molar ratio, as well as in mitochondrial membranes. Increased permeability in both membrane models, moni-
tored by calcein release, seemed to correlate with the extent of MEN incorporation into membranes. MEN
perturbed the physical properties of vesicles composed of dipalmitoylphosphatidylcholine or dipalmitoylphos-
phatidylethanolamine plus tetraoleoylcardiolipin (at 7:3 molar ratio), as reﬂected by the downshift of the lipid
phase transition temperature and the emergence of a new transition peak in the mixed lipid system, detected
by DSC. 31P NMR studies revealed that MEN favored the formation of non-lamellar structures. Also, quenching
studieswith theﬂuorescent probes DPH and TMA-DPH showed thatMENdistributed across the bilayer thickness
in bothmodel and nativemitochondrial membranes. MEN's ability to promote alterations ofmembrane lipid or-
ganizationwas relatedwith its reportedmitochondrial toxicity and promotion of apoptosis, predictably involved
in its anti-carcinogenic activity.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Menadione (2-methyl-1,4-naphthoquinone or vitamin K3; MEN)
is a polycyclic aromatic ketone (Fig. 1) that can function as a precur-
sor in the synthesis of vitamin K. MEN reduction at the level of theotential; cyt c, cytochrome c;
oline; DOPE, dioleoylphosphati-
A-DPH, trimethylammonium-
line; DPPE, dipalmitoylphos-
imetry; FCCP, carbonylcyanide
drial membrane; MEN, menadi-
L-α-Phosphatidylethanolamine-
orous nuclear magnetic reso-
OS, reactive oxygen species;
and Cell Biology, University of
ra, Portugal. Tel.: +351 239
rights reserved.complex I of the mitochondrial respiratory chain [1,2], which accounts
for 50% of its metabolism [2], readily diverts the electron ﬂow from
the normal ﬂux to complex II. As a quinone, MEN may undergo
one-el2ectron reduction producing a semiquinone radical, which in
turn reduces molecular oxygen into superoxide anion radical, while
being oxidized back to the initial quinone form [3]. This futile redox
cycling generating intracellular ROSmay elicit rapid oxidation of biolog-
ical molecules in both the mitochondrial matrix and cytosol, thus justi-
fying the common use of MEN as a model compound to investigate the
mechanisms of oxidative stress and apoptosis [3].
MEN pharmacological importance as a chemotherapeutic agent in
cancer diseases [4], such as leukemia [5,6], gastrointestinal [7] and
lung [8] cancers, has been reported. Positive outcomes of the admin-
istration of MEN on pancreatic [9] and prostate cancer, in this case in
association with vitamin C [10], have been recognized too. However,
the exposure to MEN has also been associated with several adverse
effects, including hemolytic anemia [11,12], cardiotoxicity [13], hepa-
totoxicity [14] and neuronal damage [15].
Fig. 1. Chemical structure of menadione (2-methyl-1,4-naphthoquinone).
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high proneness to incorporate into membrane environments. Studies
performed in our laboratories have shown that many lipophilic com-
pounds, such as clinically-used drugs [16–19] and environmental pol-
lutants, including insecticides [20–23] and organotins [24], promote
alterations of membrane physical properties, with repercussions in
membrane-associated functions, including those related to mitochon-
drial bioenergetics. Consistently, MEN membrane incorporation has
been reported to enhance membrane ﬂuidity, this mechanism having
been proposed to mediate MEN toxicity in rat hepatocytes [25]. On
the other hand, MEN was found to affect mitochondrial respiration,
as reﬂected by changes in several respiratory parameters, namely an
increase in respiratory state 4 and a decrease in the respiratory con-
trol index and ADP/O ratio [26]. MEN-induced increase in state 4 res-
piration has been assigned to increased basal permeability of the
inner mitochondrial membrane (IMM) to protons, which may result
from membrane physical perturbations.
Fluidity is a critical property of membranes that interferes with the
activity of membrane proteins [27] and modulates membrane perme-
ability [28]. However, the full picture of drug-membrane interactions
and their functional repercussionsmay involve further characterization
of membrane physical properties, such as curvature stress associated to
the lipid propensity to form non-lamellar-phases. This type of lipid
assemblies has been proposed to play a role in cell fusion and ﬁssion
processes [29] and in the recruitment of proteins involved in signal
ampliﬁcation [30,31]. Hexagonal II structures (HII) have been proposed
to be present at membrane contact sites such as those between the
inner and outer mitochondrial membranes, where the mitochondrial
permeability transition (MPT) pore is thought to be formed [32]. MPT
was suggested as being essential forMEN-elicited apoptosis, promoting
efﬂux of cytochrome c (cyt c) into the cytoplasm and subsequent activa-
tion of caspases 9 and 3 [33]. Although it has been reported that MEN
induced MPT [34] by a process involving direct oxidation of mitochon-
drial pyridine nucleotides and modiﬁcation of critical thiols of MPT
pore components [35], other mechanisms may underlie MEN effects
on this process.
Attempting to approach membrane physical effects exerted by
MEN, which could be associated with the impairment of mitochon-
dria functioning and apoptosis, biophysical studies were carried out
in the present work employing diverse techniques and a variety of
membrane preparations. These included membrane models mimicking
the cardiolipin-enriched IMM (where most mitochondrial proteins lie),
namely at the contact sites between inner and outer mitochondrial
membranes (where MPT pore is formed), and native mitochondrial
membranes.
These studies provided evidence that MEN affected membrane
physical properties, which could be critical for membrane proteinactivity and susceptible of compromising important mitochondria-
driven physiological processes, including cell death, hence unveiling
novel targets forMEN to exert its action either therapeutic or detrimental.
2. Materials and methods
2.1. Chemicals
The lipids dipalmitoylphosphatidylcholine (DPPC), palmitoyloleoyl-
phosphatidylcholine (POPC), dioleoylphosphatidylcholine (DOPC),
dipalmitoylphosphatidylethanolamine (DPPE), dioleoylphosphatidyl-
ethanolamine (DOPE), tetraoleoylcardiolipin (TOCL) (at least 98% pure)
and the ﬂuorescent lipid probe L-α-Phosphatidylethanolamine-N-(4-
nitrobenzo-2-oxa-1,3-diazole) (NBD-PE) were obtained from Avanti
Polar Lipids, Inc. (Murcia, Spain). MEN was purchased from Sigma
Chemical Co. (St. Louis, MO, USA). The probes calcein, 1,6-diphenyl-
1,3,5-hexatriene (DPH) and trimethylammonium-diphenylhexatriene
(TMA-DPH) were purchased from Molecular Probes, Inc. (Eugene, OR,
USA). All the other chemicals were of the highest commercially avail-
able purity.
2.2. Preparation of multilamellar vesicles (MLVs)
Adequate portions of DPPC or mixtures of DPPE:TOCL (7:3 molar
ratio) and DOPC:DOPE:TOCL (1:1:1 molar ratio) were dissolved in
chloroform, and subsequently evaporated to dryness in a rotary evap-
orator. The dry residues were hydrated under N2 atmosphere by gen-
tle shaking with an adequate volume of buffer (10 mM Tris-maleate
plus 50 mM KCl, pH 7.0, for DPPC and DPPE:TOCL liposomes and
50 mM HEPES plus 0.2 mM NaCl, pH 7.5, for DOPC:DOPE:TOCL lipo-
somes) at a temperature above the transition phase of the respective
lipid preparations (room temperature for the ternary unsaturated
lipid mixture, 55 °C for DPPC and 65 °C for DPPE:TOCL mixture).
DPPC and DPPE:TOCL preparations (150 mM in lipid), used in DSC
assays, and DOPC:DOPE:TOCL preparations (5 mg), used in 31P NMR
assays were vortexed three times during 1 min to disperse aggregates.
MENwas then added to the liposome suspensions from a concentrated
ethanolic solution, and the preparations were allowed to equilibrate
overnight at the temperatures at which liposomes were prepared
(i.e. at temperatures above Tm). Control samples were prepared
with equivalent volumes of ethanol, which were always less than
3% of the total volume of the sample. Negligible effects were exerted
by these amounts of ethanol (b3% v/v) on the studied membrane
systems as detected by the different techniques.
2.3. Preparation of large unilamellar vesicles (LUVs)
For the spectrophotometric and spectroﬂuorimetric measure-
ments, LUVs were prepared from the corresponding MLV suspen-
sions. Therefore, adequate portions of lipid (POPC, DPPC or a
mixture of DOPC:DOPE:TOCL at 1:1:1 molar ratio) were dissolved in
chloroform, and MLVs were prepared in buffer (50 mM HEPES plus
0.2 mM NaCl, pH 7.5 for POPC and DOPC:DOPE:TOCL liposomes and
10 mM Tris-maleate plus 50 mM KCl, pH 7.0, for DPPC liposomes)
as previously described, at the concentration of 5 mM for binding
studies, 40 mM for calcein release assays and 1.8 mM for ﬂuorescence
quenching and derivative spectrophotometry assays. For binding
assays, NBD-PE in chloroform was mixed with lipids, before drying
and hydration, in order to obtain a concentration of 1 mol% in
MLVs. For calcein release measurements, a buffer containing 30 mM
calcein was used for the hydration of lipids and MLVs were submitted
to several freeze/thaw cycles. MLV suspensions were then extruded 10
times through 100 nm nucleopore polycarbonate ﬁlters (Whatman
Millipore, USA) to obtain LUV suspensions. In the case of calcein release
studies, a molecular exclusion chromatography was subsequently
performed to exclude the excess of free probe.
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Mitochondrial membranes prepared from isolated mitochondria
[36] and resealed after 5 freeze/thaw cycles in liquid nitrogen were
kept at 4 °C, in a buffer (10 mM Tris-maleate, 50 mM KCl; pH 8.5) to
which the protease inhibitor phenylmethylsulfonyl ﬂuoride (PMSF,
10 μM) was added. The protein content was determined by the biuret
method [37]. Samples containing 2.48 mg of protein/mL (correspond-
ing to a lipid concentration of approximately 400 μM [38]) were used
in ﬂuorescence quenching studies.
2.5. Incorporation of the probes DPH and TMA-DPH
A small volume of the ﬂuorescent probe (DPH or TMA-DPH) solu-
tion in dimethylformamide (DMF) was injected into 345 μM LUV sus-
pensions to obtain a probe:lipid molar ratio of 1:300. LUVs were
incubated overnight in the dark, before the incorporation of MEN. In
the case of mitochondrial membrane suspensions, ﬂuorescent probes
were added to attain a probe:lipid molar ratio of 1:200 and the prep-
arations were incubated at least for 1 h. Control samples were pre-
pared with equivalent volumes of probe solvent (DMF), which were
always less than 3% of the total volume of the sample and showed
to have no effect on experimental measurements.
2.6. Spectrophotometric measurements
The partition coefﬁcient (Kp) of MEN between membranes and aque-
ous buffered solutions was assessed using derivative spectrophotometry,
without physical phase separation. Buffered solutions ofMENwere added
to unilamellar vesicles composed of DPPC or DOPC:DOPE:TOCL (1:1:1
molar ratio) or to mitochondrial membranes, in order to obtain a ﬁxed
concentration of drug (34 μM) and increasing concentrations of lipids
(100–1000 μM). Reference lipid suspensions were prepared in the ab-
sence of drug. The absorption spectra of lipid suspensions containing or
notMENwere recorded in the 220–520 nm range, at 50 °C for DPPC lipo-
somes; 25 and 70 °C for the mixture DOPC:DOPE:TOCL and 25, 37 and
50 °C formitochondrialmembranes, in amultidetectionmicroplate read-
er (Synergy HT; Bio-Tek Instruments), accordingly to a well established
protocol [39]. Due to temperature control requirement at high tempera-
ture (70 °C), the Kp of MEN in the mixture DOPC:DOPE:TOCL was per-
formed in a conventional spectrophotometer (JASCO V-660). The
mathematical treatment of the results was performed using a developed
routine, Kp Calculator [39]. This routine allows to i) subtract each refer-
ence spectrum from the corresponding sample spectrum to obtain
corrected absorption spectra, ii) determine the second and third deriva-
tive spectra in order to eliminate the spectral interferences due to light
scattered by the lipid vesicles and to enhance the ability to detect minor
spectral features and to improve the resolution of bands, and iii) calculate
the Kp values (M−1) by a nonlinear ﬁtting method.
2.7. Spectroﬂuorimetric measurements
2.7.1. Binding studies
The extent of the interaction of MEN with membrane models
(80 μM in lipid) was evaluated by monitoring the ﬂuorescence of
the incorporated lipid probe NBD-PE in the wavelength range of 490
to 650 nm, following excitation at 465 nm, using a Perkin-Elmer LS 55
Luminescence Spectrometer. The values obtained at the emission
peak (528 nm) for each MEN concentration were subtracted from
the intensity of ﬂuorescence of a control sample without MEN (but
containing a volume of ethanol corresponding to the maximum
amount of MEN solution assayed). The differences between the ﬂuo-
rescence intensities were expressed as percentages of the total ﬂuo-
rescence of the control and then plotted as a function of MEN to lipid
molar ratio.2.7.2. Calcein release studies
Unilamellar vesicles (100 μM in lipid) containing entrapped
calcein were incubated with MEN for 10 min at room temperature.
The extent of calcein release was determined bymonitoring the ﬂuores-
cence in thewavelength range from 495 to 580 nm, following excitation
at 490 nm, using a Perkin-Elmer LS 55 Luminescence Spectrometer. The
values obtained at the emission peak (510 nm) were normalized to the
total amount of calcein released after disruption of vesicles with 0.1%
Triton X-100 and plotted as a function of MEN to lipid molar ratio.
The percentage of calcein release induced by X concentration of
the compound, reﬂecting the permeability of vesicle membranes
(% Px), was calculated using the following formula:
%Px ¼ IX−IC
IT
⋅100 ð1Þ
where, IX is the ﬂuorescence intensity with X concentration of the com-
pound, IC is the control ﬂuorescence intensity and IT is the maximal
ﬂuorescence intensity after lysis by Triton X-100. Ethanol (an amount
equivalent to that of MEN solution added to the samples) had no signif-
icant effect on calcein release.
2.7.3. Fluorescence quenching
Fluorescence quenching assays in unilamellar vesicles or mito-
chondrial membranes containing DPH or TMA-DPH and MEN or eth-
anol (control) were performed in a Perkin-Elmer LS 55 Luminescence
Spectrometer at controlled temperatures (50 °C for DPPC liposomes;
25 and 70 °C for the mixture DOPC:DOPE:TOCL and 25, 37 and
50 °C for the mitochondrial membranes). Excitation wavelength
was set at 357 and 361 nm for acquisition of emission spectra of
DPH and TMA-DPH, respectively, and the emission wavelength was
set at 427 nm for excitation spectra acquisition for both probes. Fluo-
rescence values were corrected for light scattering contributions by
subtracting the intensities from unlabeled samples at the same condi-
tions: such contributions were always negligible (less than 0.5%). All
ﬂuorescence intensity data were corrected from reabsorbtion and
inner ﬁlter effects [40].
Fluorescence lifetime measurements were made with a Fluorolog
Tau-3 Lifetime system. Modulation frequencies were acquired be-
tween 5 and 110 MHz. Integration time was 8 s. Manual slits used
were 1.0 mm, slits for excitation monochromator were 7.000 (side
entrance) and 0.5 mm (side exit) and for emission monochromator
7.000 (side entrance) and 7.000 (side exit). All measurements were
made using Ludox as a reference standard (τ = 0.00 ns).
2.8. Differential scanning calorimetry
Multilamellar vesicles (150 mM in phospholipid) prepared as de-
scribed above, containing different amounts of MEN in order to obtain
drug:lipid molar ratios from 1:6 to 1:48, or ethanol (control), were
sealed into aluminum pans and heating scans were performed over
an appropriate temperature range, on a Perkin-Elmer Pyris 1 differen-
tial scanning calorimeter at a scan rate of 5 °C/min. To check data re-
producibility, three heating scans were recorded for each sample. To
compensate the effect of high heat capacity of the aqueous medium
on the baseline, an estimated amount of buffer was used in the refer-
ence pan. Data acquisition and analysis were performed using the
software provided by Perkin Elmer. Distinct temperatures were auto-
matically deﬁned for each endotherm: the onset temperature (T0)
and the temperature at the endotherm peak (Tm). To deﬁne the
range of the phase transition or lateral phase separation (Tf–T0), a
third temperature was determined (Tf) by extrapolating to the base-
line a tangent to the descendent slope of the endothermic peak. These
critical transition temperatures were estimated as the mean value of
three heating scans in at least three different samples from the
same preparation. To determine the total amount of phospholipid
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the experiment and the content was dissolved in chloroform plus
methanol. The phospholipid content was determined by measuring
the amount of inorganic phosphate [41], after hydrolysis of the ex-
tracts in 70% HClO4, at 180 °C, for 60 min [42]. Finally, peak proﬁles
and enthalpy (ΔH) values were normalized to the exact phospholipid
content in each pan.
2.9. 31P NMR
For 31P NMR studies, preparations containing 5 mg of a mixture of
DOPC:DOPE:TOCL (1:1:1) were obtained as described above. MEN
was added to the liposome suspensions from a concentrated ethanolic
solution and the preparations were allowed to stabilize overnight. The
samples were loaded into a 5-mm diameter NMR tube and a small vol-
ume of a CaCl2 solution was added to reach 1:1 Ca2+:cardiolipin molar
ratio. Controls were prepared with a few μl of ethanol, corresponding to
the volume of the MEN solution assayed. Spectra were obtained using a
Varian Unity 500 NMR spectrometer operating at 202.33 MHz with a
5-mm broadband probe over a 30-kHz sweep width with 60 × 1024
data points. A 90° pulse width of 14.09 μs was used. Composite pulse
decoupling allowed to remove any proton coupling. Generally, 800
free induction decays were acquired and processed using an exponen-
tial line broadening of 100 Hz prior to Fourier transformation. Probe
temperature was maintained to ±0.2 °C by the variable temperature
unit of the NMR spectrometer.
2.10. Statistical analysis of data
DSC and ﬂuorescence data, namely transition temperature mid-
points (Tm), transition temperature ranges (Tf–T0), enthalpy changes
(ΔH) and quenching percentageswere expressed asmeans ± standard
deviation of 3–4 independent experiments. Multiple comparisons were
performed using one-way ANOVAwith the Student–Newman–Keuls as
a post-test. A value of P b 0.05 was considered statistically signiﬁcant.
3. Results
3.1. Menadione binding to membrane model systems depends on lipid
composition
The interaction of increasing concentrations of MEN with
NBD-PE-containing unilamellar vesicles composed of POPC (electri-
cally neutral) or DOPC:DOPE:TOCL at 1:1:1 molar ratio (negatively
charged) induced a progressive decrease of the ﬂuorescence intensity
of the lipid probe. This effect, which can be assigned to binding or in-
corporation of the drug to/into NBD-PE-containing lipid bilayers, results
from the high sensitivity of the ﬂuorescent probe to the dielectric con-
stant of its environment [43]. As expected, data obtained with both
membrane systems pointed to a saturation type dynamics, indicating
that MEN incorporation attained a limit at certain concentrations,
which were much higher in POPC than in DOPC:DOPE:TOCL vesicles.
In fact, the maximal difference between the ﬂuorescence intensities at
the peak of emission in the presence and in the absence of MEN was
twofold in the former vesicles as compared to the latter (Fig. 2A). This
means that MEN bound/incorporated more strongly to the neutral
bilayers than to those displaying a negative charge.
3.2. Menadione increases membrane permeability to calcein
The effects of MEN on membrane permeability were addressed by
using the ﬂuorescent probe calcein, encapsulated in unilamellar vesi-
cles with the same composition of those assayed for binding. The con-
centration at which calcein was encapsulated in vesicles promoted
self-quenching of the probe. Therefore, membrane destabilization ac-
companied by calcein release was assessed by an increase of theﬂuorescence intensity, as self-quenching decreased. As shown in
Fig. 2B, MEN increased the permeability of both membrane systems
assayed, but the membrane disturbance induced by MEN was stron-
ger for POPC vesicles than for the lipid mixture. This is consistent
with the higher binding or incorporation of the drug observed in
the former vesicles (Fig. 2A), indicating that increased incorporation
led, as expected, to more drastic effects on membrane permeability.
3.3. Menadione exhibits high partition coefﬁcients in membrane model
systems and mitochondrial membranes
The determination of MEN partition coefﬁcients (Kp) by UV–VIS de-
rivative spectrophotometrywas based on the change of spectral charac-
teristics of the drug when it left the aqueous solution and incorporated
into the lipid phase. The derivative spectra ofMEN incorporated in LUVs
or mitochondrial membranes exhibited a bathochromic shift in λmin
(i.e. the λ at which a selected peak of the derivative spectrum attained
a minimum value) up to 2 nm as the lipid concentration increased.
This observation provided a clear indication that the drug partitions
from the aqueous to the lipid media [39]. MEN Kp values for all the sys-
tems studied (Table 1) were obtained by a nonlinear least-squares re-
gression method (Fig. 3) at wavelengths at which the light scattering
was very low. The partition of MEN in vesicles composed of DOPC:
DOPE:TOCL was not assessed at 70 °C, due to the formation of tatters
in the vesicle suspension, which interfered with absorbance measure-
ments, promoting high light scattering.
The incorporation of MEN into membranes showed to be deeply
dependent on membrane composition and temperature (Table 1).
The higher MEN partition in DPPC vesicles as compared to vesicles
composed of a lipid mixture showed a signiﬁcant parallelism with
the higher binding of MEN (assessed by the NBD-PE assay) and the
higher MEN-induced membrane permeabilization (evaluated by
calcein release) observed for the former membranes relative to the
latter. Taking into account that both membranes are in the ﬂuid
phase at the temperatures of the assays (50 °C for DPPC vesicles
and 25 °C for vesicles of the lipid mixture), their different abilities
to incorporate MEN should be assigned to the charge of phospholipid
components, negatively charged membranes offering a less favorable
medium for MEN incorporation. Since cardiolipin is an anionic phos-
pholipid existing in a signiﬁcant amount in mitochondrial membranes,
partition values in these membranes similar to those obtained in the
mitochondrial membrane-mimicking model would be expected. The
higher partition of MEN in the native membranes should result from a
high afﬁnity of MEN formembrane proteins or from an extra incorpora-
tion of the drug through the lipid-protein boundaries. On the other
hand, the increase of MEN partition in the ﬂuid mitochondrial mem-
branes at increasing temperatures should reﬂect a decrease of lipid
packing, favoring MEN penetration within the lipid bilayer.
3.4. Menadione affects the thermotropic behavior of membrane lipid
models
DSC studies were performed to investigate the effects of MEN on
the membrane biophysical properties of two membrane models:
DPPC liposomes, as a classical model system for biophysical studies,
and a mixed lipid system containing DPPE plus TOCL (representing
two important lipid classes of the IMM). DSC thermograms of DPPC
bilayers showed, as expected two typical endotherms (Fig. 4A), corre-
sponding to the pre-transition at 35.6 °C, with a low enthalpy change,
and the main transition, from a gel to a liquid-crystalline phase,
detected as a sharp peak centered at 42.4 °C with an enthalpy change
of 38.5 J/g (Table 2). MEN abolished the pre-transition peak (Fig. 4A),
even at the lowest concentration assayed (MEN:DPPC molar ratio of
1:48), and increasing concentrations of MEN induced a shift of the
main transition temperature towards progressively lower tempera-
tures; the highest MEN concentration assayed promoted a decrease
Fig. 2. Interaction of MEN with unilamellar vesicles composed of POPC (squares, full line), or DOPC:DOPE:TOCL (1:1:1) mixture (circles, dashed line), as monitored by NBD-PE
(A) and calcein release (B). In the binding studies (A), the extent of MEN incorporation into the membrane models was evaluated as the differences between the ﬂuorescence
intensity (ΔF) of NBD-PE incorporated in a control sample (containing a volume of ethanol corresponding to the maximum amount of MEN solution assayed) and in samples
containing different MEN:lipid molar ratios, expressed as percentages of the total ﬂuorescence of the control, at 528 nm (corresponding to the peak of NBD-PE emission spectrum).
In the calcein release studies (B), data are presented as differences between the ﬂuorescence intensity of calcein, at 510 nm, in MEN-containing and control preparations, normalized as
percentages of the maximal ﬂuorescence intensity corresponding to the total (100%) release of calcein, induced by Triton X-100.
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broadening of DPPC main transition, reﬂecting a decrease of the
cooperativity, and an increase of the enthalpy (Table 2).
Liposomes prepared from DPPE and TOCL at a molar ratio of 7:3
showed a single, but broad (Tf–T0≈10 °C) endotherm centered at
about 48.2 °C (Fig. 4B and Table 2). This behavior was expected taking
into account that the lipid components of thismixture hold, when isolat-
ed, a large gap between their transition temperatures (64 °C for DPPE
and below 0 °C for TOCL) as previously reported [44]. This mixture is
prone to undergo lateral phase separation. The addition of MEN to
these liposomes promoted the emergence of a new endothermic peak
with a higher transition temperature than that of the control lipid prep-
aration (without drug), suggesting the formation of DPPE-enriched lipid
domains. Regarding the enthalpies of the transitions (ΔH), the sumof the
enthalpies corresponding to the two endotherms exhibited by MEN-
containing lipid preparations was approximately equivalent to the en-
thalpy of the control preparation, conﬁrming the occurrence of a lateral
phase separation (Table 2). On the other hand, the enthalpy of the sec-
ond peak signiﬁcantly increased as the concentration of MEN increased
(from 1:12 to 1:6 MEN:lipid molar ratio), reﬂecting an enlargement of
the segregated DPPE-enriched domains (Table 2). Interestingly, this
peak was also shifted to lower temperatures as MEN concentration
increased.
3.5. Menadione changes the membrane phase equilibrium in mixed
non-bilayer and bilayer lipid systems favoring the hexagonal II phase
The effect of MEN on lipid mesomorphism exhibited by a ternary
lipid system containing bilayer (DOPC) and non-bilayer prone phos-
pholipids (DOPE and TOCL plus calcium) was investigated by 31PTable 1
Partition coefﬁcients of MEN obtained in a biphasic membrane/aqueous system. The
partition was determined for vesicles composed of DPPC at 50 °C, a lipid mixture
containing DOPC:DOPE:TOCL (1:1:1) at 25 °C and isolated mitochondrial membranes
at 25 °C, 37 °C and 50 °C.
Lipid Temperature
(°C)
Kp
(M−1)
DPPC 50.0 ± 0.1 2299 ± 288
Lipid mixture 25.0 ± 0.1 1603 ± 198
Mitochondrial membranes 25.0 ± 0.1 2823 ± 204
37.0 ± 0.1 3598 ± 108
50.0 ± 0.1 7781 ± 407NMR. This mixture mimicked the IMM, since it contained the three
major components of that membrane. The mixture of DOPC:DOPE:
TOCL:Ca2+ (1:1:1:1 molar ratio) at 25 °C is mainly organized in ex-
tended bilayers (giving rise to the characteristic asymmetrical 31P
NMR lineshape with a low-ﬁeld shoulder and a high-ﬁeld peak [45]
separated by approximately 10 ppm), but part of the component
lipids is organized in an inverted hexagonal phase, as evidenced by
the small peak downﬁeld of phosphoric acid (set at 0 ppm) which
became more evident in the spectrum as the temperature increased
(Fig. 5). At 70 °C, the HII phase notoriously predominated relatively
to the bilayer component, an effect likely prompted by the presence
of Ca2+ which compels CL to form non-lamellar arrangements [46].
The incorporation of MEN (at a molar ratio of 1:6 to lipid) affected
lipid phase behavior, the HII phase becoming clearly the predominant
component above 25 °C.
3.6. Menadione location within the membrane depended on membrane
lipid composition and structure
The preferential location of MEN along the depth of the bilayer
was investigated by steady-state and time-resolved ﬂuorescenceFig. 3. Fitting curve to experimental third-derivative spectrophotometric data at
298 nm (where the scattering is very low or null) as a function of lipid concentration
(LUVs composed of DOPC:DOPE:TOCL at 1:1:1 molar ratio) at 25 °C, using a nonlinear
least squares regression method.
Fig. 4. DSC thermograms of liposomes prepared from DPPC (A) or a mixture of DPPE and TOCL at a 7:3 molar ratio (B), in the absence (cont.) or presence of MEN at the MEN:lipid
molar ratios indicated on the scans. The DSC proﬁles were originated from heating scans. The thermograms are typical assays of at least three independent experiments.
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core [47], and TMA-DPH, which due to its charged group anchored at
the lipid water interface reports the region of the bilayer correspond-
ing to the upper portions of the lipid hydrocarbon chains [48].
Since only drug molecules distributed in the membrane are able to
quench the probes inserted in lipid bilayers, the effective concentra-
tions of MEN within the membrane ([MEN]m) rather than the total
concentrations of the drug ([MEN]T) were used in the subsequent
ﬂuorescent quenching studies to localize MEN through the mem-
brane thickness. In order to calculate membrane effective concentra-
tions of MEN, Kp values were used in the following equation [40]:
MEN½ m ¼
Kp MEN½ T
Kpαm þ 1−αmð Þ
ð2Þ
whereαm is the volume fraction of membrane phase (αm = Vm/VT; Vm
and VT representing the volumes of the membrane and water phases,
respectively). For vesicles of DOPC:DOPE:TOCL at 70 °C, the [MEN]m
for the same system at 25 °Cwas used, since the Kpwas not determined
at the high temperature due to the difﬁculties previously referred,Table 2
Characterization of the phase transitions detected by DSC (temperature of the endothermic p
DPPC or DPPE:TOCL (7:3). Liposomes were incubated with MEN to obtain different drug:lipi
maximal volume of the MEN solution assayed) for the respective control (MEN:lipid molar
MEN:lipid molar ratio Tm
(°C)
Tf–T0
(°C)
MEN:DPPC Peak 1
0 (control) 42.43 ± 0.4096⁎⁎⁎ 2.25 ± 0.1849
1:48 41.53 ± 0.2145ns 2.75 ± 0.05462⁎
1:24 40.74 ± 0.2228⁎ 3.14 ± 0.07364⁎
1:12 40.32 ± 0.2191⁎⁎ 3.56 ± 0.07209⁎⁎
1:6 39.36 ± 0.1759⁎⁎ 4.48 ± 0.3725⁎⁎
MEN:lipid mixture
0 (control) 48.16 ± 2.00 9.45 ± 1.98
1:12 46.79 ± 1.72ns 10.53 ± 1.71⁎
1:6 45.19 ± 0.34⁎ 11.07 ± 2.05⁎⁎
a) Values presented are means ± standard deviation of three to four DSC experiments. Comp
post-test for the following paired observations: liposomes with each MEN:lipid molar ratio
⁎⁎⁎ P b 0.001.
⁎⁎ P b 0.01.
⁎ P b 0.05.probably caused by the formation of hexagonal phases as demonstrated
by 31P NMR.
InDPPC vesicles,MEN induced a concentration dependent reduction
of DPH and TMA-DPH ﬂuorescence (Fig. 6A and B). The extent of ﬂuo-
rescence quenching induced in both probes was evaluated by plotting
steady-state ﬂuorescence (F0/F) and lifetime measurements (τ0/τ) as
a function of MEN concentration (Fig. 6C and D) according to the
Stern–Volmer equations [40]:
F0
F
¼ 1þ KSV MEN½  ð3Þ
τ0
τ
¼ 1þ KD MEN½  ð4Þ
where (F, τ) and (F0, τ0) are steady-state ﬂuorescence intensities and
lifetimes in the presence and in the absence of MEN, respectively, and
KSV and KD are the Stern–Volmer constants, which indicate the exten-
sion of quenching.Whereas KSV reﬂects the occurrence of both dynamic
(collisional) and static (resulting from the formation of a complexeak, Tm, transition temperature range, Tf–To, and enthalpy change, ΔH) in liposomes of
d molar ratios (indicated in the Table) or with a few μl of ethanol (corresponding to the
ratio of zero in the Table).
ΔH
(J/g)
Tm 2
(°C)
ΔH 2
(J/g)
Peak 2
38.54 ± 0.5618 – –
39.68 ± 0.3734ns – –
41.48 ± 0.7017⁎ – –
42.08 ± 0.6974⁎ – –
43.16 ± 1.240⁎ – –
20.18 ± 0.77 – –
19.80 ± 0.79⁎ 57.82 ± 0.60 0.41 ± 0.22
18.11 ± 0.56⁎⁎ 54.62 ± 1.92⁎ 2.79 ± 0.79⁎⁎
arisons were performed using one-way ANOVA, with the Student–Newman–Keuls as a
vs. control liposomes (without MEN). n.s., not signiﬁcant.
Fig. 6. Quenching effects of MEN on the emission of DPH (A) and TMA-DPH (B) incorporated
themembranes,measured at 427 nm. The corresponding Stern–Volmer plots are represented fo
plotswere obtained from steady stateﬂuorescencemeasurements (black circles) and fromﬂuor
and (4) (dotted line). Results are representative of at least three independent determinations fo
Newman–Keuls as a post-test for the following paired observations: LUVswith amembraneME
**, P b 0.01; *, P b 0.05; ns, not signiﬁcant.
Fig. 5. 31P NMR spectra of aqueous dispersions of DOPC:DOPE:TOCL (1:1:1) with CaCl2
(1:1 to cardiolipin) at different temperatures (indicated in the ﬁgure), in the absence
(Control) or the presence of MEN at a 1:6 drug to phospholipid molar ratio (Menadione).
For each sample, the spectrumwas ﬁrst averaged at 25 °C over a period of about 20 min,
and then the process was repeated over a range of temperatures with 15 °C increments.
Each sample (600 μl) contained 5 mg of total lipid.
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exclusively a dynamic quenching process.
As shown in Fig. 6C and D, the dynamic quenching represented by
the lifetime Stern–Volmer plot (dotted line) was lower than the
quenching gathered from steady-state ﬂuorescence measurements
(solid line) for both probes, indicating the occurrence of an additional
static quenching process, which did not inﬂuence excited state life-
times. Therefore, the quenching process was analyzed by a modiﬁed
form of the Stern–Volmer equation, which accounts for the additional
static quenching [40]:
F0
F 1þ KD MEN½ ð Þ
¼ 1þ KS MEN½ ð Þ: ð5Þ
This expression contemplates the dynamic quenching component
characterized by the dynamic Stern–Volmer constant KD, as well as the
static component, characterized by the static Stern–Volmer constant KS.
The KD component was experimentally determined as the slope of the
lifetime measurement plot. On the other hand, a plot of (F0/F) / (1+KD
[menadione]) versus [menadione] yielded a straight line with an inter-
cept of 1 and a slope of KS (data not shown).
The quenching parameters obtained from the analysis of the Stern–
Volmer plots (KD from collisional quenching, KS from static quenching
and KSV, as the sum of both contributions) are shown in Table 3.in DPPC unilamellar vesicles as a function of the effective concentrations of MENwithin
r the probesDPH (C) and TMA-DPH (D) as a function ofMEN concentration. Stern–Volmer
escence lifetimemeasurements (white circles). Lines are the bestﬁt for Eqs. (3) (solid line)
r each condition. Comparisons were performed using one-way ANOVA,with the Student–
N concentration of 0.009, 0.018, 0.036, 0.048 or 0.072 μMvs. control LUVs (withoutMEN);
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the bimolecular quenching rate constant (Kq = KD/τ0) [40] was cal-
culated. This parameter, also shown in Table 3, reﬂects the efﬁciency
of quenching, which in the case of the present study depends on the
accessibility of MEN molecules to the ﬂuorescent probe, eliminating
speciﬁcities related with the ﬂuorescence lifetime of the probe (τ0).
The analysis of Table 3 data, showing that the Kq value obtained
with TMA-DPH incorporated in vesicles of DPPC was higher than
that with DPH, suggests a preference of MEN to locate at the shallow
hydrophobic regions of DPPC bilayers.
Aiming at establishing a correlation between MEN membrane in-
teractions and its effects on mitochondria, quenching analyses were
extended to other more realistic membrane model composed of a
lipid mixture of DOPC:DOPE:TOCL at 1:1:1 molar ratio, and also to
suspensions of isolated mitochondrial membranes.
Regarding the lipid mixture model at 25 °C, at which temperature
31P NMR data showed that hexagonal phases already prevailed in the
presence of MEN, this compound exhibited a preference to be local-
ized closer to the upper regions of lipid acyl chains, monitored by
TMA-DPH. Indeed, in these conditions, the Kq value obtained with
TMA-DPH was about 87.5% higher than that with DPH. At 70 °C,
when HII lipid arrangement clearly predominated, MEN also showed
a preferential localization closer to the upper regions of the fatty
acyl chains, since the Kq value obtained with TMA-DPH was twice
that obtained with DPH. It is worth mentioning that when the lipid
mixture in the presence of MEN adopted predominantly an inverted
hexagonal structure (at 70 °C), Kq values for DPH and TMA-DPH
were respectively 6.9 and 7.3 times higher than those obtained at
25 °C (Table 3), temperature at which a signiﬁcant component
assigned to the lamellar structure was still detected in the 31P NMR
spectrum of the MEN-containing lipid mixture. Although being
aware that MEN effective concentration in this lipid system was not
determined at 70 °C, it is fair to suggest that the signiﬁcant increase
of the Kq value at this temperature indicates that MEN was more
efﬁciently incorporated in this lipid system when arranged in a HII
structure, which may justify its tendency to favor this phase to the
detriment of the lamellar phase when both phases coexist, as
revealed by 31P NMR data.
In isolated mitochondrial membranes, MEN showed a preferential
location in the inner bilayer regions close to DPH, which displayed
higher quenching by MEN as compared to TMA-DPH. The nature
of the quenching process also differed for the two probes. MENTable 3
Values of probe lifetimes (τm) and of the Stern–Volmer constant corresponding to the dyna
quenching (KSV), as well as the bimolecular quenching constant (Kq) obtained frommeasure
vesicles composed of DPPC or a lipid mixture of DOPC:DOPE:TOCL (1:1:1) with Ca2+ 1:1 to c
were also performed at the temperature range from 25 to 50 °C.
Lipid Probe KD (M−1) (a) KS (M−
DPPC DPH 1.6 ± 0.2 6.9 ± 0
TMA-DPH 1.1 ± 0.1⁎ 3.3 ± 0
Lipid mixture 25 °C (Lα phase) DPH 1.41 ± 0.06 1.19 ±
TMA-DPH 1.16 ± 0.08⁎ 0.98 ±
Lipid mixture 70 °C (HII phase) DPH 6.3 ± 0.1 12.7 ±
TMA-DPH 2.4 ± 0.02⁎⁎ 2.1 ± 0
Mitochondrial membranes 25 °C DPH 8.5 ± 0.8 –
TMA-DPH 1.72 ± 0.02⁎⁎ 2.92 ±
Mitochondrial membranes 37 °C DPH 8.0 ± 0.8 –
TMA-DPH 1.4 ± 0.2⁎⁎ 1.1 ± 0
Mitochondrial membranes 50 °C DPH 8.0 ± 0.3 –
TMA-DPH 1.49 ± 0.03⁎⁎ –
(a) KD values were calculated from the slope of the lifetime linear plots (τ0/τ versus [MEN
(b) KS values were calculated from the slope of the linear plots (F0/F) / (1+KD [Q]) versus
(c) τm values were calculated by the following expression: τm ¼
X2
i¼1
f iτi , where fi is the fra
(d) Kq values were calculated using the KD values and experimental τ0 of the probe.
Values presented are mean ± standard deviation of at least three experiments. Compari
post-test for the following paired observations: lipid models labelled with TMA-DPH vs. co
⁎⁎ P b 0.001.
⁎ P b 0.05.quenched DPH ﬂuorescence exclusively by a dynamic, collisional
process.
In contrast, MEN-induced quenching of TMA-DPH ﬂuorescence in-
volved besides a dynamic process a static one, which resulted from
the formation of a non-ﬂuorescent ground-state complex between
the probe and MEN. Taking into account TMA-DPH localization in
the bilayer, it seems reasonable to propose that MEN bounds electro-
statically to the head groups of phospholipids. At the highest temper-
ature assayed, the static quenching component disappeared due to
complete dissociation of the weakly bound drug-probe complexes
and TMA-DPH quenching became exclusively collisional in nature.
4. Discussion
MEN generates intracellular ROS at multiple cellular sites through
futile redox cycling [49]. MENbiological activity has been shown to pro-
mote either favorable or deleterious effects on cellular functioning. Low
levels of MEN-induced oxidative stress have shown to mimic endoge-
nous oxidant signals that trigger protection against ischemic injury in
the heart [50]. In contrast, higher concentrations ofMENwere proposed
to induce toxic oxidative stress associated with tissue injury, mitochon-
drial DNA damage, and cell death [51–54], and MEN genotoxicity has
been attributed to its ability to damage DNA via ROS generation [55].
On the other hand, therapeutic beneﬁts of MEN have been described
in the treatment of several types of cancer [5–8].
MEN's capacity to promote lipid peroxidation, associated with its
high propensity to incorporate into membranes due to its lipophilic
character [55], has been related to MEN-induced human cancer cell
degeneration [56]. MEN incorporation into membranes was demon-
strated in the present work using liposomes of different composition
and isolated mitochondrial membranes. Concomitant disturbances of
membrane physical properties were also detected by different tech-
niques (DSC, 31P NMR), likely related with MEN-induced increase of
membrane permeability, as deduced by the calcein release assays
(Fig. 2). Noteworthy, curves representing MEN-membrane binding/
incorporation and MEN-induced calcein release as function of drug
concentration allow foreseeing a relationship between MEN mem-
brane interaction and disturbing effects. The increase of calcein re-
lease from lipid vesicles in the presence of MEN might be associated
to a decrease of lipid packing, which would favor the generation of
small free volumes, hence facilitating calcein diffusion across the
lipid bilayer. However, more efﬁciently than a moderate increase ofmic quenching (KD), the static quenching (KS), and the combination of the two types of
ments of ﬂuorescence quenching of DPH and TMA-DPH at different MEN:lipid ratios, for
ardiolipin at 25 °C or 70 °C. Quenching studies with isolated mitochondrial membranes
1) (b) KSV (M−1) τmX10−9 (s) (c) Kq X109 (M−1s−1) (d)
.2 8.6 ± 0.5 7.45 ± 0.05 0.22 ± 0.2
.2⁎⁎ 4.5 ± 0.3⁎⁎ 2.68 ± 0.04 0.4 ± 0.1⁎⁎
0.04 2.6 ± 0.1 8.70 ± 0.04 0.16 ± 0.1
0.03⁎ 2.2 ± 0.2⁎ 3.85 ± 0.04 0.3 ± 0.1⁎⁎
0.1 19.0 ± 0.2 5.77 ± 0.08 1.1 ± 0.2
.1⁎⁎ 4.6 ± 0.1⁎⁎ 1.09 ± 0.05 2.2 ± 0.2⁎
8.5 ± 0.8 5.14 ± 0.02 1.6 ± 0.8
0.04 4.65 ± 0.06⁎⁎ 2.35 ± 0.04 0.73 ± 0.06⁎⁎
8.0 ± 0.8 5.00 ± 0.06 1.6 ± 0.9
.2 2.6 ± 0.4⁎⁎ 2.09 ± 0.02 0.7 ± 0.3⁎⁎
8.0 ± 0.3 4.66 ± 0.05 1.7 ± 0.3
1.49 ± 0.03⁎⁎ 1.77 ± 0.03 0.84 ± 0.06⁎⁎
]) based on Eq. (4).
[MEN] based on Eq. (5).
ctional contribution of component i to the total lifetime.
sons were performed using one-way ANOVA, with the Student–Newman–Keuls as a
rresponding lipid models labelled with DPH at the same temperature.
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with the appearance of discontinuities and defect lines in the inter-
face regions between lipid domains at different phases, has shown
to promote an increase of membrane permeability [57]. Consistently,
DSC studies carried out in a mixed lipid system (7 DPPE: 3 TOCL)
showed that MEN induced the segregation of DPPE-enriched domains
(Fig. 4B), revealing its capacity to promote lateral phase separation.
On the other hand, an increase of MEN concentration promoted a
downshift of the transition temperature of the DPPE-segregated do-
mains (Fig. 4B) as well as of the DPPC liposomes (Fig. 4A), reﬂecting
the disordering effect associated with the incorporation of MEN in
lipid bilayers. An uneven distribution of MEN into the membrane is
suggested by its preferential interaction with zwitterionic phospho-
lipids: DPPE in themixture of DPPE:TOCL, as deduced fromDSC studies;
and DPPC/POPC bilayers rather than the DOPC:DOPE:TOCL negatively
charged membranes, as demonstrated by partition, binding and calcein
release studies (Fig. 2 and Table 1). Therefore, it is expected that in
protein-enriched heterogeneous membranes, such as native mitochon-
drial membranes, MEN should exert a high perturbation of membrane
lipid organization. The higher quenching of DPH as compared with
TMA-DPH in these membranes, at all temperatures tested, including
the physiologic one (Table 3), indicates a deep location of MEN within
the lipid bilayer. On the other hand, 31P NMR studies, using membrane
models composed of the threemost representative lipid classes ofmito-
chondrial membranes (PC, PE and CL) in the presence of Ca2+ (an im-
portant cation in mitochondria functioning regulation), showed that
MEN induced an increased propensity for non-lamellar phase genera-
tion (Fig. 5). Altogether, these effects could result in an increase of the
permeability of mitochondrial membranes, which could be on the
basis of the reported MEN-induced increase of mitochondrial state 4
respiration (a state of passive respiration relying on proton diffusion
across the IMM [26]) and decrease of mitochondrial transmembrane
potential (ΔΨ) [33]. Moreover, the perturbation of membrane physical
properties could lead to the opening of pores in themembrane through
which not only ions could diffuse, but also small molecules could be
released. Consistently, MEN-induced activation of apoptosis has been
associated with a decrease of ΔΨ and the release of cyt c from mito-
chondria to the cytosol [33]. MPT has also been proposed as being in-
volved in this process, its induction being mediated by ROS generation
through MEN redox-cycling mechanism [58]. However, our results
showed that other mechanisms should be involved in the process by
whichMEN inducedMPT. Thus, the highMEN propensity to induce lat-
eral phase separation inmembranemodels containing CL, alongwith its
proneness to promote the formation of non-lamellar phases (Fig. 5)
maymodulateMEN action in CL-enrichedmitochondrial membrane re-
gions like the contact sites between the inner and outer mitochondrial
membranes [59], where structures of high curvature have been pro-
posed to be present [32] and MPT pore is thought to be formed [60].
In conclusion, this study provides a signiﬁcant amount of data show-
ing that MEN holds a remarkablemembrane activity, whichmatches its
action as an apoptosis enhancer. Moreover, these data provide new
elements for understanding previous results regarding MEN toxic
effects on rat hepatocytes [25] or MEN-induced apoptosis mediated by
MPTand involvingmitochondrial cyt c release [33]. Finally, the biophys-
ical approach toMEN cellular effects, namely regarding the induction of
mitochondrial-mediated apoptosis, should provide new targets to be
addressed by MEN or similar compounds in the treatment of diseases
such as cancer, where the induction of apoptosis could constitute a ther-
apeutic strategy.
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